Health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes

BACKGROUND: Glucagon-like peptide-1 (GLP-1) receptor agonists are often recommended as part of combination therapy for type 2 diabetes when oral medication does not result in sufficient glycemic control. Several GLP-1 receptor agonists are available as weekly injections. These medications vary in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Matza, Louis S., Boye, Kristina S., Stewart, Katie D., Davies, Evan W., Paczkowski, Rosirene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702146/
https://www.ncbi.nlm.nih.gov/pubmed/29178918
http://dx.doi.org/10.1186/s12913-017-2648-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702146/
https://www.ncbi.nlm.nih.gov/pubmed/29178918
http://dx.doi.org/10.1186/s12913-017-2648-7

Ejemplares similares